Skip to content
2000
Volume 20, Issue 4
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background

Mycophenolate mofetil (MMF) is an immunosuppressant commonly used for treating autoimmune diseases.

Case Presentation

We report a diagnostically challenging case of MMF-induced colitis in a patient after 3 years of initiation of MMF therapy. A 76-year-old Caucasian female with a history of chronic inflammatory demyelinating polyneuropathy receiving MMF presented to the hospital with a 7-weeks history of watery diarrhoea and crampy abdominal pains. Routine blood investigations, CMV-PCR, stool culture, viral PCR, Colonoscopy, and CT scan of the abdomen were broadly within normal limits. Histopathological changes were not significantly diagnostic apart from ischaemic-type changes. Finally, the reduction of the MMF dose caused the cessation of diarrhoea. Diagnosing MMF-induced colitis can be challenging, especially in patients on immunosuppressive medications. Further, long latency periods and non-specific colonoscopic and histopathologic changes add to the diagnostic dilemma.

Conclusion

MMF-induced diarrhoea should be part of the clinician’s differentials, and the decision to reduce the dose of MMF needs to be considered once infection and other causes have been ruled out.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863318109241104111738
2025-01-02
2025-07-19

  • From This Site

    /content/journals/cds/10.2174/0115748863318109241104111738
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. AllisonA.C. EuguiE.M. Mycophenolate mofetil and its mechanisms of action.Immunopharmacology2000472-38511810.1016/S0162‑3109(00)00188‑010878285
     [Google Scholar]
  2. CalmetF.H. YarurA.J. PukazhendhiG. AhmadJ. BhamidimarriK.R. Endoscopic and histological features of mycophenolate mofetil colitis in patients after solid organ transplantation.Ann. Gastroenterol.201528336637326126799
     [Google Scholar]
  3. MaesBD DalleI GeboesK OellerichM ArmstrongVW EvenepoelP Erosive enterocolitis in mycophenolate mofetil-treated renal-transplant recipients with persistent afebrile diarrhea.Transplantation.20037556657210.1097/01.TP.0000053753.43268.F0
     [Google Scholar]
  4. DaviesNM GrinyóJ HeadingR MaesB Meier-KriescheHU OellerichM Gastrointestinal side effects of mycophenolic acid in renal transplant patients: A reappraisal.Nephrol Dial Transplant.20072292440810.1093/ndt/gfm308
     [Google Scholar]
  5. LeeF.D. Importance of apoptosis in the histopathology of drug related lesions in the large intestine.J. Clin. Pathol.199346211812210.1136/jcp.46.2.1188459031
     [Google Scholar]
  6. de AndradeL.G.M. RodriguesM.A.M. RomeiroF.G. GarciaP.D. ConttiM.M. de CarvalhoM.F.C. Clinicopathologic features and outcome of mycophenolate‐induced colitis in renal transplant recipients.Clin. Transplant.201428111244124810.1111/ctr.1245225142167
     [Google Scholar]
  7. DhakalP. GamiR. GiriS. BhattV.R. MofetilM. Mycophenolate Mofetil (MMF)-Induced Colitis.Blood201612822479510.1182/blood.V128.22.4795.4795
     [Google Scholar]
  8. SelbstM.K. AhrensW.A. RobertM.E. FriedmanA. ProctorD.D. JainD. Spectrum of histologic changes in colonic biopsies in patients treated with mycophenolate mofetil.Mod. Pathol.200922673774310.1038/modpathol.2009.4419329937
     [Google Scholar]
  9. GoyalA. SalahuddinM. GovilY. A unique case of mycophenolate induced colitis after 10 years of use.Case Rep. Gastrointest. Med.201620161310.1155/2016/305840727668102
     [Google Scholar]
  10. BandelierC. GuerneP-A. GenevayS. FinckhA. GabayC. Clinical experience with mycophenolate mofetil in systemic autoimmune conditions refractory to common immunosuppressive therapies.Swiss Med. Wkly.20091393-4414610.4414/smw.2009.1244119169902
     [Google Scholar]
  11. Al SaadiW Al SalmiI MohammedE Al AjmiZ HannawiS. Mycophenolate induced colitis: One-year post-kidney transplantation.Oman Med J.2023382e48910.5001/omj.2023.14
     [Google Scholar]
  12. FarooqiR KamalA BurkeC. Mycophenolate-induced colitis: A case report with focused review of literature.Cureus.2020121e677410.7759/cureus.6774
     [Google Scholar]
  13. MoronciniG. BenfaremoD. MandolesiA. GabrielliA. Mycophenolate mofetil-induced colitis in a patient with systemic sclerosis.BMJ Case Rep.20182018bcr-2018-22482910.1136/bcr‑2018‑22482929776943
     [Google Scholar]
  14. SrinivasTR Meier-KriescheH-U Minimizing immunosuppression, an alternative approach to reducing side effects: Objectives and interim result.Clin J Am Soc Nephrol.20083Suppl 2S1011610.2215/CJN.03510807
     [Google Scholar]
  15. BouhbouhS. RookmaakerM.B. Rapid resolution of persistent mycophenolate mofetil-induced diarrhoea with a single dose of infliximab.Nephrol. Dial. Transplant.201025103437343810.1093/ndt/gfq37920615909
     [Google Scholar]
/content/journals/cds/10.2174/0115748863318109241104111738
Loading

  • Article Type:     Case Report
Keyword(s): adverse drug reaction; colitis; diarrhoeas; latency period; MMF; Mycophenolate mofetil

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test